-
1
-
-
23044452436
-
Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins
-
Abdelrahim M, Safe S. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol 68: 317–329, 2005.
-
(2005)
Mol Pharmacol
, vol.68
, pp. 317-329
-
-
Abdelrahim, M.1
Safe, S.2
-
2
-
-
84873719174
-
Prevention and treatment of colorectal cancer by natural agents from mother nature
-
Aggarwal B, Prasad S, Sung B, Krishnan S, Guha S. Prevention and treatment of colorectal cancer by natural agents from mother nature. Curr Colorectal Cancer Rep 9: 37–56, 2013.
-
(2013)
Curr Colorectal Cancer Rep
, vol.9
, pp. 37-56
-
-
Aggarwal, B.1
Prasad, S.2
Sung, B.3
Krishnan, S.4
Guha, S.5
-
3
-
-
0029451275
-
Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
-
Alberts DS, Hixson L, Ahnen D, Bogert C, Einspahr J, Paranka N, Brendel K, Gross PH, Pamukcu R, Burt RW. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biol Suppl 22: 18–23, 1995.
-
(1995)
J Cell Biol Suppl
, vol.22
, pp. 18-23
-
-
Alberts, D.S.1
Hixson, L.2
Ahnen, D.3
Bogert, C.4
Einspahr, J.5
Paranka, N.6
Brendel, K.7
Gross, P.H.8
Pamukcu, R.9
Burt, R.W.10
-
4
-
-
37549036729
-
Survivin, cancer networks and pathway-directed drug discovery
-
Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61–70, 2008.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 61-70
-
-
Altieri, D.C.1
-
5
-
-
80053305857
-
Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
-
Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci 89: 545–554, 2011.
-
(2011)
Life Sci
, vol.89
, pp. 545-554
-
-
Amado, N.G.1
Fonseca, B.F.2
Cerqueira, D.M.3
Neto, V.M.4
Abreu, J.G.5
-
6
-
-
84937506891
-
-
American Cancer Society. Colorectal Cancer Detailed Guide. American Cancer Society
-
American Cancer Society. Colorectal Cancer Detailed Guide. American Cancer Society, 2013. http://www.cancer.org/acs/groups/cid/documents/ webcontent/003096-pdf.pdf
-
(2013)
-
-
-
7
-
-
33144470373
-
Sporadic adenomatous polyp regression with exisulind is effective but toxic: A randomised, double blind, placebo controlled, dose-response study
-
Arber N, Kuwada S, Leshno M, Sjodahl R, Hultcrantz R, Rex D. Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study. Gut 55: 367–373, 2006.
-
(2006)
Gut
, vol.55
, pp. 367-373
-
-
Arber, N.1
Kuwada, S.2
Leshno, M.3
Sjodahl, R.4
Hultcrantz, R.5
Rex, D.6
-
8
-
-
84860309759
-
Genetic alterations in colorectal cancer
-
Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res 5: 19–27, 2012.
-
(2012)
Gastrointest Cancer Res
, vol.5
, pp. 19-27
-
-
Armaghany, T.1
Wilson, J.D.2
Chu, Q.3
Mills, G.4
-
9
-
-
82255183575
-
Dietary fibre, whole grains, and risk of colorectal cancer: Systematic review and dose-response meta-analysis of prospective studies
-
Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343: d6617, 2011.
-
(2011)
BMJ
, vol.343
, pp. 6617
-
-
Aune, D.1
Chan, D.S.2
Lau, R.3
Vieira, R.4
Greenwood, D.C.5
Kampman, E.6
Norat, T.7
-
10
-
-
13444282673
-
Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein
-
Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 67: 356–364, 2005.
-
(2005)
Mol Pharmacol
, vol.67
, pp. 356-364
-
-
Baek, S.J.1
Kim, J.S.2
Moore, S.M.3
Lee, S.H.4
Martinez, J.5
Eling, T.E.6
-
11
-
-
0035060429
-
Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities
-
Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59: 901–908, 2001.
-
(2001)
Mol Pharmacol
, vol.59
, pp. 901-908
-
-
Baek, S.J.1
Kim, K.S.2
Nixon, J.B.3
Wilson, L.C.4
Eling, T.E.5
-
12
-
-
33750736082
-
Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia
-
Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131: 1553–1560, 2006.
-
(2006)
Gastroenterology
, vol.131
, pp. 1553-1560
-
-
Baek, S.J.1
Okazaki, R.2
Lee, S.H.3
Martinez, J.4
Kim, J.S.5
Yamaguchi, K.6
Mishina, Y.7
Martin, D.W.8
Shoieb, A.9
McEntee, M.F.10
Eling, T.E.11
-
13
-
-
0034807826
-
Dietary agents in cancer prevention: Flavonoids and isoflavonoids
-
Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90: 157–177, 2001.
-
(2001)
Pharmacol Ther
, vol.90
, pp. 157-177
-
-
Birt, D.F.1
Hendrich, S.2
Wang, W.3
-
14
-
-
67650297506
-
Cancer prevention and treatment with resveratrol: From rodent studies to clinical trials
-
Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila) 2: 409–418, 2009.
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 409-418
-
-
Bishayee, A.1
-
15
-
-
84890938242
-
Molecular genetics of colorectal cancer
-
Bogaert J, Prenen H. Molecular genetics of colorectal cancer. Ann Gastroenterol 27: 1–6, 2014.
-
(2014)
Ann Gastroenterol
, vol.27
, pp. 1-6
-
-
Bogaert, J.1
Prenen, H.2
-
16
-
-
84855515509
-
Chemoprevention in colorectal cancer— where we stand and what we have learned from twenty year’s experience
-
Boghossian S, Hawash A. Chemoprevention in colorectal cancer— where we stand and what we have learned from twenty year’s experience. Surgeon 10: 43–52, 2012.
-
(2012)
Surgeon
, vol.10
, pp. 43-52
-
-
Boghossian, S.1
Hawash, A.2
-
17
-
-
41049095471
-
As a therapeutic target for the treatment of metastatic colorectal cancer
-
Browning DD. Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer. Expert Opin Ther Targets 12: 367–376, 2008.
-
(2008)
Expert Opin Ther Targets
, vol.12
, pp. 367-376
-
-
Browning, D.D.1
Protein Kinase, G.2
-
18
-
-
79956123093
-
Studies on the metabolism and biological activity of the epimers of sulindac
-
Brunell D, Sagher D, Kesaraju S, Brot N, Weissbach H. Studies on the metabolism and biological activity of the epimers of sulindac. Drug Metab Dispos 39: 1014–1021, 2011.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1014-1021
-
-
Brunell, D.1
Sagher, D.2
Kesaraju, S.3
Brot, N.4
Weissbach, H.5
-
19
-
-
84855556537
-
Aspirin in the chemoprevention of colorectal neoplasia: An overview
-
Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, Logan RF, Rothwell PM, Schror K, Baron JA. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 5: 164–178, 2012.
-
(2012)
Cancer Prev Res (Phila)
, vol.5
, pp. 164-178
-
-
Chan, A.T.1
Arber, N.2
Burn, J.3
Chia, W.K.4
Elwood, P.5
Hull, M.A.6
Logan, R.F.7
Rothwell, P.M.8
Schror, K.9
Baron, J.A.10
-
20
-
-
34249884856
-
Cancer preventive mechanisms of the green tea polyphenol (_)-epigallocatechin-3-gallate
-
Chen L, Zhang HY. Cancer preventive mechanisms of the green tea polyphenol (_)-epigallocatechin-3-gallate. Molecules 12: 946–957, 2007.
-
(2007)
Molecules
, vol.12
, pp. 946-957
-
-
Chen, L.1
Zhang, H.Y.2
-
21
-
-
80052024865
-
Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome- dependent and -independent downregulation of specificity proteins (Sp) transcription factors
-
Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome- dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11: 371, 2011.
-
(2011)
BMC Cancer
, vol.11
, pp. 371
-
-
Chintharlapalli, S.1
Papineni, S.2
Lei, P.3
Pathi, S.4
Safe, S.5
-
22
-
-
0037372178
-
Inducible nitric oxide synthase expression in human colorectal cancer: Correlation with tumor angiogenesis
-
Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, Masini E. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 162: 793–801, 2003.
-
(2003)
Am J Pathol
, vol.162
, pp. 793-801
-
-
Cianchi, F.1
Cortesini, C.2
Fantappie, O.3
Messerini, L.4
Schiavone, N.5
Vannacci, A.6
Nistri, S.7
Sardi, I.8
Baroni, G.9
Marzocca, C.10
Perna, F.11
Mazzanti, R.12
Bechi, P.13
Masini, E.14
-
23
-
-
44349111717
-
Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: Is PTEN loss predictor of local recurrence?
-
Colakoglu T, Yildirim S, Kayaselcuk F, Nursal TZ, Ezer A, Noyan T, Karakayali H, Haberal M. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg 195: 719–725, 2008.
-
(2008)
Am J Surg
, vol.195
, pp. 719-725
-
-
Colakoglu, T.1
Yildirim, S.2
Kayaselcuk, F.3
Nursal, T.Z.4
Ezer, A.5
Noyan, T.6
Karakayali, H.7
Haberal, M.8
-
24
-
-
33845283897
-
Dietary phytoestrogen intake is associated with reduced colorectal cancer risk
-
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136: 3046–3053, 2006.
-
(2006)
J Nutr
, vol.136
, pp. 3046-3053
-
-
Cotterchio, M.1
Boucher, B.A.2
Manno, M.3
Gallinger, S.4
Okey, A.5
Harper, P.6
-
25
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z. Inflammation and cancer. Nature 420: 860–867, 2002.
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
26
-
-
33746353391
-
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis
-
Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4: 1035–1038, 2006.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1035-1038
-
-
Cruz-Correa, M.1
Shoskes, D.A.2
Sanchez, P.3
Zhao, R.4
Hylind, L.M.5
Wexner, S.D.6
Giardiello, F.M.7
-
27
-
-
68449094325
-
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
-
Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52: 1766–1777, 2009.
-
(2009)
Diabetologia
, vol.52
, pp. 1766-1777
-
-
Currie, C.J.1
Poole, C.D.2
Gale, E.A.3
-
28
-
-
2542619027
-
Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells
-
Deguchi A, Thompson WJ, Weinstein IB. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 64: 3966–3973, 2004.
-
(2004)
Cancer Res
, vol.64
, pp. 3966-3973
-
-
Deguchi, A.1
Thompson, W.J.2
Weinstein, I.B.3
-
29
-
-
84864022346
-
Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis
-
Dou W, Mukherjee S, Li H, Venkatesh M, Wang H, Kortagere S, Peleg A, Chilimuri SS, Wang ZT, Feng Y, Fearon ER, Mani S. Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. PloS One 7: e36075, 2012.
-
(2012)
Plos One
, vol.7
-
-
Dou, W.1
Mukherjee, S.2
Li, H.3
Venkatesh, M.4
Wang, H.5
Kortagere, S.6
Peleg, A.7
Chilimuri, S.S.8
Wang, Z.T.9
Feng, Y.10
Fearon, E.R.11
Mani, S.12
-
30
-
-
84870581169
-
Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea
-
Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ. Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4: 1679–1691, 2012.
-
(2012)
Nutrients
, vol.4
, pp. 1679-1691
-
-
Du, G.J.1
Zhang, Z.2
Wen, X.D.3
Yu, C.4
Calway, T.5
Yuan, C.S.6
Wang, C.Z.7
-
31
-
-
0025312728
-
A genetic model for colorectal tumorigenesis
-
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990.
-
(1990)
Cell
, vol.61
, pp. 759-767
-
-
Fearon, E.R.1
Vogelstein, B.2
-
32
-
-
81555222627
-
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention
-
Fischer SM, Hawk ET, Lubet RA. Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) 4: 1728–1735, 2011.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1728-1735
-
-
Fischer, S.M.1
Hawk, E.T.2
Lubet, R.A.3
-
33
-
-
0027197062
-
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
-
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313–1316, 1993.
-
(1993)
N Engl J Med
, vol.328
, pp. 1313-1316
-
-
Giardiello, F.M.1
Hamilton, S.R.2
Krush, A.J.3
Piantadosi, S.4
Hylind, L.M.5
Celano, P.6
Booker, S.V.7
Robinson, C.R.8
Offerhaus, G.J.9
-
34
-
-
0035866371
-
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis
-
Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61: 1375–1381, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 1375-1381
-
-
Gokmen-Polar, Y.1
Murray, N.R.2
Velasco, M.A.3
Gatalica, Z.4
Fields, A.P.5
-
35
-
-
1242292420
-
Genomic instability and colon cancer
-
Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev 23: 11–27, 2004.
-
(2004)
Cancer Metastasis Rev
, vol.23
, pp. 11-27
-
-
Grady, W.M.1
-
36
-
-
78650840096
-
Ibuprofen inhibits activation of nuclear _-catenin in human colon adenomas and induces the phosphorylation of GSK-3_
-
Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW. Ibuprofen inhibits activation of nuclear _-catenin in human colon adenomas and induces the phosphorylation of GSK-3_. Cancer Prev Res (Phila) 4: 161–171, 2011.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 161-171
-
-
Greenspan, E.J.1
Madigan, J.P.2
Boardman, L.A.3
Rosenberg, D.W.4
-
37
-
-
33745238704
-
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
-
Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98: 736–747, 2006.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 736-747
-
-
Grosch, S.1
Maier, T.J.2
Schiffmann, S.3
Geisslinger, G.4
-
38
-
-
77956016499
-
Cancer prevention with natural compounds
-
Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O. Cancer prevention with natural compounds. Semin Oncol 37: 258–281, 2010.
-
(2010)
Semin Oncol
, vol.37
, pp. 258-281
-
-
Gullett, N.P.1
Ruhul Amin, A.R.2
Bayraktar, S.3
Pezzuto, J.M.4
Shin, D.M.5
Khuri, F.R.6
Aggarwal, B.B.7
Surh, Y.J.8
Kucuk, O.9
-
39
-
-
84891106411
-
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
-
Gurpinar E, Grizzle WE, Piazza GA. COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs. Front Oncol 3: 181, 2013.
-
(2013)
Front Oncol
, vol.3
, pp. 181
-
-
Gurpinar, E.1
Grizzle, W.E.2
Piazza, G.A.3
-
41
-
-
0035837653
-
Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats
-
Hakkak R, Korourian S, Ronis MJ, Johnston JM, Badger TM. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett 166: 27–32, 2001.
-
(2001)
Cancer Lett
, vol.166
, pp. 27-32
-
-
Hakkak, R.1
Korourian, S.2
Ronis, M.J.3
Johnston, J.M.4
Badger, T.M.5
-
42
-
-
84884220419
-
Chemoprevention of gastrointestinal neoplasia
-
Half E, Arber N. Chemoprevention of gastrointestinal neoplasia. Curr Gastroenterol Rep 15: 320, 2013.
-
(2013)
Curr Gastroenterol Rep
, vol.15
, pp. 320
-
-
Half, E.1
Arber, N.2
-
43
-
-
33744976813
-
Metformin inhibits cytokineinduced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells
-
Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokineinduced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47: 1183–1188, 2006.
-
(2006)
Hypertension
, vol.47
, pp. 1183-1188
-
-
Hattori, Y.1
Suzuki, K.2
Hattori, S.3
Kasai, K.4
-
44
-
-
2342430345
-
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: Arrows point the way
-
He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663–1677, 2004.
-
(2004)
Development
, vol.131
, pp. 1663-1677
-
-
He, X.1
Semenov, M.2
Tamai, K.3
Zeng, X.4
-
45
-
-
84872529696
-
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
-
Hirsch HA, Iliopoulos D, Struhl K. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci USA 110: 972–977, 2013.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 972-977
-
-
Hirsch, H.A.1
Iliopoulos, D.2
Struhl, K.3
-
46
-
-
0035503939
-
Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenasedependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues
-
Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenasedependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol 62: 1175–1183, 2001.
-
(2001)
Biochem Pharmacol
, vol.62
, pp. 1175-1183
-
-
Hong, J.1
Smith, T.J.2
Ho, C.T.3
August, D.A.4
Yang, C.S.5
-
47
-
-
0034332541
-
Cancer chemoprevention in the 21st century: Genetics, risk modeling, and molecular targets
-
Hong WK, Spitz MR, Lippman SM. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol 18: 9S–18S, 2000.
-
(2000)
J Clin Oncol
, vol.18
, pp. 9SS-18S
-
-
Hong, W.K.1
Spitz, M.R.2
Lippman, S.M.3
-
48
-
-
64849117472
-
Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation
-
Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ, Lai LP. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int J Cardiol 134: 169–175, 2009.
-
(2009)
Int J Cardiol
, vol.134
, pp. 169-175
-
-
Huang, N.L.1
Chiang, S.H.2
Hsueh, C.H.3
Liang, Y.J.4
Chen, Y.J.5
Lai, L.P.6
-
49
-
-
84860331563
-
Proteomic analysis of the effects of baicalein on colorectal cancer cells
-
Huang WS, Kuo YH, Chin CC, Wang JY, Yu HR, Sheen JM, Tung SY, Shen CH, Chen TC, Sung ML, Liang HF, Kuo HC. Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics 12: 810–819, 2012.
-
(2012)
Proteomics
, vol.12
, pp. 810-819
-
-
Huang, W.S.1
Kuo, Y.H.2
Chin, C.C.3
Wang, J.Y.4
Yu, H.R.5
Sheen, J.M.6
Tung, S.Y.7
Shen, C.H.8
Chen, T.C.9
Sung, M.L.10
Liang, H.F.11
Kuo, H.C.12
-
50
-
-
0038445608
-
Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas
-
Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230–232, 2003.
-
(2003)
Lancet
, vol.362
, pp. 230-232
-
-
Huls, G.1
Koornstra, J.J.2
Kleibeuker, J.H.3
-
51
-
-
58849166880
-
NSAIDs and colorectal cancer prevention
-
Iwama T. NSAIDs and colorectal cancer prevention. J Gastroenterol 44, Suppl 19: 72–76, 2009.
-
(2009)
J Gastroenterol
, vol.44
, pp. 72-76
-
-
Iwama, T.1
-
52
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 61: 69–90, 2011.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
53
-
-
84875039955
-
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
-
Jin H, Gong W, Zhang C, Wang S. Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling. Onco Targets Ther 6: 145–153, 2013.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 145-153
-
-
Jin, H.1
Gong, W.2
Zhang, C.3
Wang, S.4
-
54
-
-
0035937335
-
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
-
Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84: 844–850, 2001.
-
(2001)
Br J Cancer
, vol.84
, pp. 844-850
-
-
Jung, Y.D.1
Kim, M.S.2
Shin, B.A.3
Chay, K.O.4
Ahn, B.W.5
Liu, W.6
Bucana, C.D.7
Gallick, G.E.8
Ellis, L.M.9
-
55
-
-
28844469924
-
Molecular mechanism of nrf2 activation by oxidative stress
-
Kang KW, Lee SJ, Kim SG. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal 7: 1664–1673, 2005.
-
(2005)
Antioxid Redox Signal
, vol.7
, pp. 1664-1673
-
-
Kang, K.W.1
Lee, S.J.2
Kim, S.G.3
-
56
-
-
4444229304
-
Colorectal cancer prevention
-
Kauh J, Umbreit J. Colorectal cancer prevention. Curr Probl Cancer 28: 240–264, 2004.
-
(2004)
Curr Probl Cancer
, vol.28
, pp. 240-264
-
-
Kauh, J.1
Umbreit, J.2
-
57
-
-
84885042534
-
Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice
-
Kim DH, Hossain MA, Kang YJ, Jang JY, Lee YJ, Im E, Yoon JH, Kim HS, Chung HY, Kim ND. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int J Oncol 43: 1652–1658, 2013.
-
(2013)
Int J Oncol
, vol.43
, pp. 1652-1658
-
-
Kim, D.H.1
Hossain, M.A.2
Kang, Y.J.3
Jang, J.Y.4
Lee, Y.J.5
Im, E.6
Yoon, J.H.7
Kim, H.S.8
Chung, H.Y.9
Kim, N.D.10
-
58
-
-
84937398982
-
Modulation of colitis-associated colon tumorigenesis by baicalein and betaine
-
Kim DH, Sung B, Chung HY, Kim ND. Modulation of colitis-associated colon tumorigenesis by baicalein and betaine. J Cancer Prev 19: 153–160, 2014.
-
(2014)
J Cancer Prev
, vol.19
, pp. 153-160
-
-
Kim, D.H.1
Sung, B.2
Chung, H.Y.3
Kim, N.D.4
-
59
-
-
31044449825
-
Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: A possible mechanism of the growth inhibitory effect of genistein
-
Kim EJ, Shin HK, Park JH. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of genistein. J Med Food 8: 431–438, 2005.
-
(2005)
J Med Food
, vol.8
, pp. 431-438
-
-
Kim, E.J.1
Shin, H.K.2
Park, J.H.3
-
60
-
-
77955699748
-
Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway
-
Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, Kim SJ, Kim J, Choi C, Kim JS, Cho SD, Jung JW, Roh KH, Kang KS, Jung JY. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem 58: 8643–8650, 2010.
-
(2010)
J Agric Food Chem
, vol.58
, pp. 8643-8650
-
-
Kim, H.J.1
Kim, S.K.2
Kim, B.S.3
Lee, S.H.4
Park, Y.S.5
Park, B.K.6
Kim, S.J.7
Kim, J.8
Choi, C.9
Kim, J.S.10
Cho, S.D.11
Jung, J.W.12
Roh, K.H.13
Kang, K.S.14
Jung, J.Y.15
-
61
-
-
0038498213
-
Survivin and molecular pathogenesis of colorectal cancer
-
Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362: 205–209, 2003.
-
(2003)
Lancet
, vol.362
, pp. 205-209
-
-
Kim, P.J.1
Plescia, J.2
Clevers, H.3
Fearon, E.R.4
Altieri, D.C.5
-
62
-
-
84868515328
-
Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells
-
Kim SJ, Kim HJ, Kim HR, Lee SH, Cho SD, Choi CS, Nam JS, Jung JY. Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells. Mol Med Rep 6: 1443–1449, 2012.
-
(2012)
Mol Med Rep
, vol.6
, pp. 1443-1449
-
-
Kim, S.J.1
Kim, H.J.2
Kim, H.R.3
Lee, S.H.4
Cho, S.D.5
Choi, C.S.6
Nam, J.S.7
Jung, J.Y.8
-
63
-
-
54949114722
-
Antitumor activities of synthetic and natural stilbenes through antiangiogenic action
-
Kimura Y, Sumiyoshi M, Baba K. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci 99: 2083–2096, 2008.
-
(2008)
Cancer Sci
, vol.99
, pp. 2083-2096
-
-
Kimura, Y.1
Sumiyoshi, M.2
Baba, K.3
-
64
-
-
84873954423
-
Target-oriented mechanisms of novel herbal therapeutics in the chemotherapy of gastrointestinal cancer and inflammation
-
Ko JK, Auyeung KK. Target-oriented mechanisms of novel herbal therapeutics in the chemotherapy of gastrointestinal cancer and inflammation. Curr Pharm Des 19: 48–66, 2013.
-
(2013)
Curr Pharm Des
, vol.19
, pp. 48-66
-
-
Ko, J.K.1
Auyeung, K.K.2
-
65
-
-
84897643844
-
Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer
-
Koh SJ, Kim JM, Kim IK, Ko SH, Kim JS. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer. J Gastroenterol Hepatol 29: 502–510, 2014.
-
(2014)
J Gastroenterol Hepatol
, vol.29
, pp. 502-510
-
-
Koh, S.J.1
Kim, J.M.2
Kim, I.K.3
Ko, S.H.4
Kim, J.S.5
-
66
-
-
84880166822
-
Prevention and intervention trials for colorectal cancer
-
Komiya M, Fujii G, Takahashi M, Iigo M, Mutoh M. Prevention and intervention trials for colorectal cancer. Jpn J Clin Oncol 43: 685–694, 2013.
-
(2013)
Jpn J Clin Oncol
, vol.43
, pp. 685-694
-
-
Komiya, M.1
Fujii, G.2
Takahashi, M.3
Iigo, M.4
Mutoh, M.5
-
67
-
-
3042857722
-
Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil
-
Koo JY, Kim HJ, Jung KO, Park KY. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food 7: 117–121, 2004.
-
(2004)
J Med Food
, vol.7
, pp. 117-121
-
-
Koo, J.Y.1
Kim, H.J.2
Jung, K.O.3
Park, K.Y.4
-
68
-
-
34248573808
-
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaBregulated gene products
-
Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaBregulated gene products. Cancer Res 67: 3853–3861, 2007.
-
(2007)
Cancer Res
, vol.67
, pp. 3853-3861
-
-
Kunnumakkara, A.B.1
Guha, S.2
Krishnan, S.3
Diagaradjane, P.4
Gelovani, J.5
Aggarwal, B.B.6
-
69
-
-
24944542887
-
The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers
-
Lawes DA, Pearson T, Sengupta S, Boulos PB. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer 93: 472–477, 2005.
-
(2005)
Br J Cancer
, vol.93
, pp. 472-477
-
-
Lawes, D.A.1
Pearson, T.2
Sengupta, S.3
Boulos, P.B.4
-
70
-
-
77649341172
-
Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy
-
Li F, Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 1805: 167–180, 2010.
-
(2010)
Biochim Biophys Acta
, vol.1805
, pp. 167-180
-
-
Li, F.1
Sethi, G.2
-
71
-
-
0038243190
-
Thompson WJ. _-Catenin signaling: Therapeutic strategies in oncology
-
Li H, Pamukcu R, Thompson WJ. _-Catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther 1: 621–625, 2002.
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 621-625
-
-
Li, H.1
Pamukcu, R.2
-
72
-
-
33847199795
-
Wnt signaling and human diseases: What are the therapeutic implications?
-
Luo J, Chen J, Deng ZL, Luo X, Song WX, Sharff KA, Tang N, Haydon RC, Luu HH, He TC. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest 87: 97–103, 2007.
-
(2007)
Lab Invest
, vol.87
, pp. 97-103
-
-
Luo, J.1
Chen, J.2
Deng, Z.L.3
Luo, X.4
Song, W.X.5
Sharff, K.A.6
Tang, N.7
Haydon, R.C.8
Luu, H.H.9
He, T.C.10
-
73
-
-
67650230896
-
Wnt/beta-catenin signaling: Components, mechanisms, and diseases
-
MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9–26, 2009.
-
(2009)
Dev Cell
, vol.17
, pp. 9-26
-
-
Macdonald, B.T.1
Tamai, K.2
He, X.3
-
74
-
-
70449640434
-
Curcumin synergizes with resveratrol to inhibit colon cancer
-
Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer 61: 544–553, 2009.
-
(2009)
Nutr Cancer
, vol.61
, pp. 544-553
-
-
Majumdar, A.P.1
Banerjee, S.2
Nautiyal, J.3
Patel, B.B.4
Patel, V.5
Du, J.6
Yu, Y.7
Elliott, A.A.8
Levi, E.9
Sarkar, F.H.10
-
75
-
-
0031661654
-
Inhibition of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)
-
Malkinson AM, Koski KM, Dwyer-Nield LD, Rice PL, Rioux N, Castonguay A, Ahnen DJ, Thompson H, Pamukcu R, Piazza GA. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis 19: 1353–1356, 1998.
-
(1998)
Carcinogenesis
, vol.19
, pp. 1353-1356
-
-
Malkinson, A.M.1
Koski, K.M.2
Dwyer-Nield, L.D.3
Rice, P.L.4
Rioux, N.5
Castonguay, A.6
Ahnen, D.J.7
Thompson, H.8
Pamukcu, R.9
Piazza, G.A.10
-
76
-
-
0030992045
-
Effects of sulindac on sporadic colorectal adenomatous polyps
-
Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, Oka T. Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 40: 344–349, 1997.
-
(1997)
Gut
, vol.40
, pp. 344-349
-
-
Matsuhashi, N.1
Nakajima, A.2
Fukushima, Y.3
Yazaki, Y.4
Oka, T.5
-
77
-
-
24944568488
-
Dynamics of colorectal cancer
-
Michor F, Iwasa Y, Lengauer C, Nowak MA. Dynamics of colorectal cancer. Semin Cancer Biol 15: 484–493, 2005.
-
(2005)
Semin Cancer Biol
, vol.15
, pp. 484-493
-
-
Michor, F.1
Iwasa, Y.2
Lengauer, C.3
Nowak, M.A.4
-
78
-
-
84870341344
-
Splice isoforms as therapeutic targets for colorectal cancer
-
Miura K, Fujibuchi W, Unno M. Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 33: 2311–2319, 2012.
-
(2012)
Carcinogenesis
, vol.33
, pp. 2311-2319
-
-
Miura, K.1
Fujibuchi, W.2
Unno, M.3
-
79
-
-
0035934070
-
Risk of cardiovascular events associated with selective COX-2 inhibitors
-
Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954–959, 2001.
-
(2001)
JAMA
, vol.286
, pp. 954-959
-
-
Mukherjee, D.1
Nissen, S.E.2
Topol, E.J.3
-
80
-
-
0035076924
-
Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential
-
Narayana KR, Reddy MS, Chaluvadi MR, Krishna DR. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential. Indian J Pharmacol 33: 2–16, 2001.
-
(2001)
Indian J Pharmacol
, vol.33
, pp. 2-16
-
-
Narayana, K.R.1
Reddy, M.S.2
Chaluvadi, M.R.3
Krishna, D.R.4
-
81
-
-
35348921199
-
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: In vivo evidence
-
Narayanan BA, Reddy BS, Bosland MC, Nargi D, Horton L, Randolph C, Narayanan NK. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence. Clin Cancer Res 13: 5965–5973, 2007.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 5965-5973
-
-
Narayanan, B.A.1
Reddy, B.S.2
Bosland, M.C.3
Nargi, D.4
Horton, L.5
Randolph, C.6
Narayanan, N.K.7
-
83
-
-
84869995154
-
Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide- induced NF-kappaB activation in Caco-2 and SW480 human colon cancer cells
-
Panaro MA, Carofiglio V, Acquafredda A, Cavallo P, Cianciulli A. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide- induced NF-kappaB activation in Caco-2 and SW480 human colon cancer cells. Br J Nutr 108: 1623–1632, 2012.
-
(2012)
Br J Nutr
, vol.108
, pp. 1623-1632
-
-
Panaro, M.A.1
Carofiglio, V.2
Acquafredda, A.3
Cavallo, P.4
Cianciulli, A.5
-
84
-
-
84880255103
-
Potential targets for prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt pathways
-
Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev 14: 2201–2205, 2013.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 2201-2205
-
-
Pandurangan, A.K.1
-
85
-
-
84890478128
-
Dietary non-nutritive factors in targeting of regulatory molecules in colorectal cancer: An update
-
Pandurangan AK, Esa NM. Dietary non-nutritive factors in targeting of regulatory molecules in colorectal cancer: an update. Asian Pac J Cancer Prev 14: 5543–5552, 2013.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 5543-5552
-
-
Pandurangan, A.K.1
Esa, N.M.2
-
86
-
-
1842584266
-
Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies
-
Park OJ, Surh YJ. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150: 43–56, 2004.
-
(2004)
Toxicol Lett
, vol.150
, pp. 43-56
-
-
Park, O.J.1
Surh, Y.J.2
-
87
-
-
77957976610
-
Colorectal cancer: Chemopreventive role of curcumin and resveratrol
-
Patel VB, Misra S, Patel BB, Majumdar AP. Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer 62: 958–967, 2010.
-
(2010)
Nutr Cancer
, vol.62
, pp. 958-967
-
-
Patel, V.B.1
Misra, S.2
Patel, B.B.3
Majumdar, A.P.4
-
88
-
-
84868146644
-
Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors
-
Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PloS One 7: e48208, 2012.
-
(2012)
Plos One
, vol.7
-
-
Pathi, S.1
Jutooru, I.2
Chadalapaka, G.3
Nair, V.4
Lee, S.O.5
Safe, S.6
-
89
-
-
84865069617
-
The influence of metformin in the etiology of selected cancers
-
Pawalowska M, Markowska A. The influence of metformin in the etiology of selected cancers. Contemp Oncol (Pozn) 16: 223–229, 2012.
-
(2012)
Contemp Oncol (Pozn)
, vol.16
, pp. 223-229
-
-
Pawalowska, M.1
Markowska, A.2
-
90
-
-
0030747817
-
Sulindac sulfone inhibits azoxymethane- induced colon carcinogenesis in rats without reducing prostaglandin levels
-
Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R. Sulindac sulfone inhibits azoxymethane- induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 57: 2909–2915, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 2909-2915
-
-
Piazza, G.A.1
Alberts, D.S.2
Hixson, L.J.3
Paranka, N.S.4
Li, H.5
Finn, T.6
Bogert, C.7
Guillen, J.M.8
Brendel, K.9
Gross, P.H.10
Sperl, G.11
Ritchie, J.12
Burt, R.W.13
Ellsworth, L.14
Ahnen, D.J.15
Pamukcu, R.16
-
91
-
-
68949180098
-
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity
-
Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B, Thaiparambil J, Coward L, Gorman G, Li Y, Sani B, Hobrath JV, Maxuitenko YY, Reynolds RC. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prev Res (Phila) 2: 572–580, 2009.
-
(2009)
Cancer Prev Res (Phila)
, vol.2
, pp. 572-580
-
-
Piazza, G.A.1
Keeton, A.B.2
Tinsley, H.N.3
Gary, B.D.4
Whitt, J.D.5
Mathew, B.6
Thaiparambil, J.7
Coward, L.8
Gorman, G.9
Li, Y.10
Sani, B.11
Hobrath, J.V.12
Maxuitenko, Y.Y.13
Reynolds, R.C.14
-
92
-
-
0030968757
-
Apoptosis primarily accounts for the growthinhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
-
Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Apoptosis primarily accounts for the growthinhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57: 2452–2459, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 2452-2459
-
-
Piazza, G.A.1
Rahm, A.K.2
Finn, T.S.3
Fryer, B.H.4
Li, H.5
Stoumen, A.L.6
Pamukcu, R.7
Ahnen, D.J.8
-
93
-
-
0029035070
-
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
-
Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, Ahnen DJ. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110–3116, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 3110-3116
-
-
Piazza, G.A.1
Rahm, A.L.2
Krutzsch, M.3
Sperl, G.4
Paranka, N.S.5
Gross, P.H.6
Brendel, K.7
Burt, R.W.8
Alberts, D.S.9
Pamukcu, R.10
Ahnen, D.J.11
-
94
-
-
0035872448
-
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
-
Piazza GA, Thompson WJ, Pamukcu R, Alila HW, Whitehead CM, Liu L, Fetter JR, Gresh WE Jr, Klein-Szanto AJ, Farnell DR, Eto I, Grubbs CJ. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res 61: 3961–3968, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 3961-3968
-
-
Piazza, G.A.1
Thompson, W.J.2
Pamukcu, R.3
Alila, H.W.4
Whitehead, C.M.5
Liu, L.6
Fetter, J.R.7
Gresh, W.E.8
Klein-Szanto, A.J.9
Farnell, D.R.10
Eto, I.11
Grubbs, C.J.12
-
95
-
-
0033895709
-
Wnt signaling and cancer
-
Polakis P. Wnt signaling and cancer. Genes Dev 14: 1837–1851, 2000.
-
(2000)
Genes Dev
, vol.14
, pp. 1837-1851
-
-
Polakis, P.1
-
96
-
-
56749184290
-
Insulin and insulin-like growth factor signalling in neoplasia
-
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8: 915–928, 2008.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 915-928
-
-
Pollak, M.1
-
97
-
-
33745226982
-
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
-
Pyrko P, Soriano N, Kardosh A, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen CS, Chen TC, Schonthal AH. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol Cancer 5: 19, 2006.
-
(2006)
Mol Cancer
, vol.5
, pp. 19
-
-
Pyrko, P.1
Soriano, N.2
Kardosh, A.3
Liu, Y.T.4
Uddin, J.5
Petasis, N.A.6
Hofman, F.M.7
Chen, C.S.8
Chen, T.C.9
Schonthal, A.H.10
-
98
-
-
79957844724
-
Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity
-
Qi W, Weber CR, Wasland K, Savkovic SD. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11: 219, 2011.
-
(2011)
BMC Cancer
, vol.11
, pp. 219
-
-
Qi, W.1
Weber, C.R.2
Wasland, K.3
Savkovic, S.D.4
-
99
-
-
58149240953
-
Natural products and colon cancer: Current status and future prospects
-
Rajamanickam S, Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 69: 460–471, 2008.
-
(2008)
Drug Dev Res
, vol.69
, pp. 460-471
-
-
Rajamanickam, S.1
Agarwal, R.2
-
100
-
-
62749170009
-
Soy isoflavones modulate azoxymethane- induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta
-
Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, Curran I, Cooke GM, Bird RP, Mehta R. Soy isoflavones modulate azoxymethane- induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. J Nutr 139: 474–481, 2009.
-
(2009)
J Nutr
, vol.139
, pp. 474-481
-
-
Raju, J.1
Bielecki, A.2
Caldwell, D.3
Lok, E.4
Taylor, M.5
Kapal, K.6
Curran, I.7
Cooke, G.M.8
Bird, R.P.9
Mehta, R.10
-
101
-
-
0034152213
-
The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention
-
Reddy BS. The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9: 239–247, 2000.
-
(2000)
Cancer Epidemiol Biomarkers Prev
, vol.9
, pp. 239-247
-
-
Reddy, B.S.1
-
102
-
-
0033565252
-
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process
-
Reddy BS, Kawamori T, Lubet RA, Steele VE, Kelloff GJ, Rao CV. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res 59: 3387–3391, 1999.
-
(1999)
Cancer Res
, vol.59
, pp. 3387-3391
-
-
Reddy, B.S.1
Kawamori, T.2
Lubet, R.A.3
Steele, V.E.4
Kelloff, G.J.5
Rao, C.V.6
-
103
-
-
0034827121
-
Resveratrol inhibits intestinal tumorigenesis and modulates host-defenserelated gene expression in an animal model of human familial adenomatous polyposis
-
Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defenserelated gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39: 102–107, 2001.
-
(2001)
Nutr Cancer
, vol.39
, pp. 102-107
-
-
Schneider, Y.1
Duranton, B.2
Gosse, F.3
Schleiffer, R.4
Seiler, N.5
Raul, F.6
-
104
-
-
82455188359
-
Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer
-
Schror K. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol 25: 473–484, 2011.
-
(2011)
Best Pract Res Clin Gastroenterol
, vol.25
, pp. 473-484
-
-
Schror, K.1
-
105
-
-
0034772953
-
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer
-
Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7: 1894–1900, 2001.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1894-1900
-
-
Sharma, R.A.1
McLelland, H.R.2
Hill, K.A.3
Ireson, C.R.4
Euden, S.A.5
Manson, M.M.6
Pirmohamed, M.7
Marnett, L.J.8
Gescher, A.J.9
Steward, W.P.10
-
106
-
-
0033575796
-
The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)
-
Shiff SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 190: 445–450, 1999.
-
(1999)
J Exp Med
, vol.190
, pp. 445-450
-
-
Shiff, S.J.1
Rigas, B.2
-
108
-
-
84880354207
-
Resveratrol-based combinatorial strategies for cancer management
-
Singh CK, George J, Ahmad N. Resveratrol-based combinatorial strategies for cancer management. Ann NY Acad Sci 1290: 113–121, 2013.
-
(2013)
Ann NY Acad Sci
, vol.1290
, pp. 113-121
-
-
Singh, C.K.1
George, J.2
Ahmad, N.3
-
109
-
-
0028867742
-
Activation of transcription factor NF-kappa B is suppressed by curcumin (Diferuloylmethane) [corrected]
-
Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270: 24995–25000, 1995.
-
(1995)
J Biol Chem
, vol.270
, pp. 24995-25000
-
-
Singh, S.1
Aggarwal, B.B.2
-
110
-
-
84864987488
-
Paraskeva C. _-Catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells
-
Smartt HJ, Greenhough A, Ordonez-Moran P, Talero E, Cherry CA, Wallam CA, Parry L, Al Kharusi M, Roberts HR, Mariadason JM, Clarke AR, Huelsken J, Williams AC, Paraskeva C. _-Catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells. Gut 61: 1306–1314, 2012.
-
(2012)
Gut
, vol.61
, pp. 1306-1314
-
-
Smartt, H.J.1
Greenhough, A.2
Ordonez-Moran, P.3
Talero, E.4
Cherry, C.A.5
Wallam, C.A.6
Parry, L.7
Al Kharusi, M.8
Roberts, H.R.9
Mariadason, J.M.10
Clarke, A.R.11
Huelsken, J.12
Williams, A.C.13
-
111
-
-
84886416382
-
The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus
-
Smiechowski B, Azoulay L, Yin H, Pollak MN, Suissa S. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus. Cancer Epidemiol Biomarkers Prev 22: 1877–1883, 2013.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 1877-1883
-
-
Smiechowski, B.1
Azoulay, L.2
Yin, H.3
Pollak, M.N.4
Suissa, S.5
-
112
-
-
58249092148
-
Insulin-insulin-like growth factor axis and colon cancer
-
Sridhar SS, Goodwin PJ. Insulin-insulin-like growth factor axis and colon cancer. J Clin Oncol 27: 165–167, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 165-167
-
-
Sridhar, S.S.1
Goodwin, P.J.2
-
113
-
-
44649108424
-
A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer
-
Sukhthankar M, Yamaguchi K, Lee SH, McEntee MF, Eling TE, Hara Y, Baek SJ. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 134: 1972–1980, 2008.
-
(2008)
Gastroenterology
, vol.134
, pp. 1972-1980
-
-
Sukhthankar, M.1
Yamaguchi, K.2
Lee, S.H.3
McEntee, M.F.4
Eling, T.E.5
Hara, Y.6
Baek, S.J.7
-
114
-
-
0142166328
-
Cancer chemoprevention with dietary phytochemicals
-
Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768–780, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 768-780
-
-
Surh, Y.J.1
-
115
-
-
0034816925
-
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
-
Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15: 2057–2072, 2001.
-
(2001)
FASEB J
, vol.15
, pp. 2057-2072
-
-
Tegeder, I.1
Pfeilschifter, J.2
Geisslinger, G.3
-
116
-
-
84883485892
-
Potential targets for colorectal cancer prevention
-
Temraz S, Mukherji D, Shamseddine A. Potential targets for colorectal cancer prevention. Int J Mol Sci 14: 17279–17303, 2013.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 17279-17303
-
-
Temraz, S.1
Mukherji, D.2
Shamseddine, A.3
-
117
-
-
0031035593
-
Sulfone metabolite of sulindac inhibits mammary carcinogenesis
-
Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 57: 267–271, 1997.
-
(1997)
Cancer Res
, vol.57
, pp. 267-271
-
-
Thompson, H.J.1
Jiang, C.2
Lu, J.3
Mehta, R.G.4
Piazza, G.A.5
Paranka, N.S.6
Pamukcu, R.7
Ahnen, D.J.8
-
118
-
-
0034234978
-
Exisulind induction of apoptosis involves guanosine 3=,5=-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin
-
Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, Pamukcu R. Exisulind induction of apoptosis involves guanosine 3=,5=-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 60: 3338–3342, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 3338-3342
-
-
Thompson, W.J.1
Piazza, G.A.2
Li, H.3
Liu, L.4
Fetter, J.5
Zhu, B.6
Sperl, G.7
Ahnen, D.8
Pamukcu, R.9
-
119
-
-
0037138743
-
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
-
Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252–266, 2002.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 252-266
-
-
Thun, M.J.1
Henley, S.J.2
Patrono, C.3
-
120
-
-
80051525438
-
Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/beta-catenin-mediated transcription in human breast tumor cells
-
Tinsley HN, Gary BD, Keeton AB, Lu W, Li Y, Piazza GA. Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/beta-catenin-mediated transcription in human breast tumor cells. Cancer Prev Res (Phila) 4: 1275–1284, 2011.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1275-1284
-
-
Tinsley, H.N.1
Gary, B.D.2
Keeton, A.B.3
Lu, W.4
Li, Y.5
Piazza, G.A.6
-
121
-
-
77958542617
-
Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition
-
Tinsley HN, Gary BD, Thaiparambil J, Li N, Lu W, Li Y, Maxuitenko YY, Keeton AB, Piazza GA. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition. Cancer Prev Res (Phila) 3: 1303–1313, 2010.
-
(2010)
Cancer Prev Res (Phila)
, vol.3
, pp. 1303-1313
-
-
Tinsley, H.N.1
Gary, B.D.2
Thaiparambil, J.3
Li, N.4
Lu, W.5
Li, Y.6
Maxuitenko, Y.Y.7
Keeton, A.B.8
Piazza, G.A.9
-
122
-
-
84937506892
-
-
US Department of Health and Human Services. NIH halts use of COX-2 inhibitor in large cancer prevention trial. NIH News, December 17 2004
-
US Department of Health and Human Services. NIH halts use of COX-2 inhibitor in large cancer prevention trial. NIH News, December 17 2004.
-
-
-
-
123
-
-
33644837942
-
Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics
-
Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6: 130–140, 2006.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 130-140
-
-
Ulrich, C.M.1
Bigler, J.2
Potter, J.D.3
-
124
-
-
18644373146
-
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
-
van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241–250, 2002.
-
(2002)
Cell
, vol.111
, pp. 241-250
-
-
Van De Wetering, M.1
Sancho, E.2
Verweij, C.3
De Lau, W.4
Oving, I.5
Hurlstone, A.6
Van Der Horn, K.7
Batlle, E.8
Coudreuse, D.9
Haramis, A.P.10
Tjon-Pon-Fong, M.11
Moerer, P.12
Van Den Born, M.13
Soete, G.14
Pals, S.15
Eilers, M.16
Medema, R.17
Clevers, H.18
-
125
-
-
84870912730
-
Diet and nutrient factors in colorectal cancer risk
-
Vargas AJ, Thompson PA. Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract 27: 613–623, 2012.
-
(2012)
Nutr Clin Pract
, vol.27
, pp. 613-623
-
-
Vargas, A.J.1
Thompson, P.A.2
-
126
-
-
4043181214
-
Cancer genes and the pathways they control
-
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 10: 789–799, 2004.
-
(2004)
Nat Med
, vol.10
, pp. 789-799
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
127
-
-
0033386977
-
The control of beta-catenin and TCF during embryonic development and cancer
-
Waltzer L, Bienz M. The control of beta-catenin and TCF during embryonic development and cancer. Cancer Metastasis Rev 18: 231–246, 1999.
-
(1999)
Cancer Metastasis Rev
, vol.18
, pp. 231-246
-
-
Waltzer, L.1
Bienz, M.2
-
128
-
-
84873026456
-
The role of anti-inflammatory drugs in colorectal cancer
-
Wang D, DuBois RN. The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med 64: 131–144, 2013.
-
(2013)
Annu Rev Med
, vol.64
, pp. 131-144
-
-
Wang, D.1
Dubois, R.N.2
-
129
-
-
84863998586
-
Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line
-
Wang H, Li Q, Chen H. Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line. PloS One 7: e40955, 2012.
-
(2012)
Plos One
, vol.7
-
-
Wang, H.1
Li, Q.2
Chen, H.3
-
130
-
-
78650240296
-
Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116
-
Wang Z, Chen H. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res 30: 4537–4545, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 4537-4545
-
-
Wang, Z.1
Chen, H.2
-
131
-
-
0033590207
-
The role of cyclooxygenases in inflammation, cancer, and development
-
Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908–7916, 1999.
-
(1999)
Oncogene
, vol.18
, pp. 7908-7916
-
-
Williams, C.S.1
Mann, M.2
Dubois, R.N.3
-
132
-
-
0035139792
-
Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer
-
Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107: 135–142, 2001.
-
(2001)
J Clin Invest
, vol.107
, pp. 135-142
-
-
Yamamoto, Y.1
Gaynor, R.B.2
-
133
-
-
0038515329
-
Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis
-
Yu W, Murray NR, Weems C, Chen L, Guo H, Ethridge R, Ceci JD, Evers BM, Thompson EA, Fields AP. Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. J Biol Chem 278: 11167–11174, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 11167-11174
-
-
Yu, W.1
Murray, N.R.2
Weems, C.3
Chen, L.4
Guo, H.5
Ethridge, R.6
Ceci, J.D.7
Evers, B.M.8
Thompson, E.A.9
Fields, A.P.10
-
134
-
-
84879641544
-
Genistein induces G2/M cell cycle arrest and apoptosis via ATM/ p53-dependent pathway in human colon cancer cells
-
Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W, Yuan CS. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/ p53-dependent pathway in human colon cancer cells. Int J Oncol 43: 289–296, 2013.
-
(2013)
Int J Oncol
, vol.43
, pp. 289-296
-
-
Zhang, Z.1
Wang, C.Z.2
Du, G.J.3
Qi, L.W.4
Calway, T.5
He, T.C.6
Du, W.7
Yuan, C.S.8
-
135
-
-
70349554099
-
Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice
-
Zhang ZM, Yang XY, Yuan JH, Sun ZY, Li YQ. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Chin Med J (Engl) 122: 1660–1665, 2009.
-
(2009)
Chin Med J (Engl)
, vol.122
, pp. 1660-1665
-
-
Zhang, Z.M.1
Yang, X.Y.2
Yuan, J.H.3
Sun, Z.Y.4
Li, Y.Q.5
-
136
-
-
0034806730
-
A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database
-
Zhao SZ, Reynolds MW, Lejkowith J, Whelton A, Arellano FM. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. Clin Ther 23: 1478–1491, 2001.
-
(2001)
Clin Ther
, vol.23
, pp. 1478-1491
-
-
Zhao, S.Z.1
Reynolds, M.W.2
Lejkowith, J.3
Whelton, A.4
Arellano, F.M.5
|